Torti, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 1.556
AS - Asia 1.451
EU - Europa 927
SA - Sud America 376
AF - Africa 44
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.357
Nazione #
US - Stati Uniti d'America 1.487
SG - Singapore 601
CN - Cina 325
BR - Brasile 303
VN - Vietnam 193
DE - Germania 167
FR - Francia 138
SE - Svezia 131
IT - Italia 122
UA - Ucraina 66
JP - Giappone 61
GB - Regno Unito 60
PL - Polonia 55
FI - Finlandia 53
IN - India 51
BD - Bangladesh 46
IE - Irlanda 44
HK - Hong Kong 38
ID - Indonesia 37
AR - Argentina 32
CA - Canada 27
MX - Messico 25
RU - Federazione Russa 23
KR - Corea 20
IQ - Iraq 17
EC - Ecuador 16
NL - Olanda 16
ZA - Sudafrica 16
TR - Turchia 14
AT - Austria 10
CO - Colombia 9
ES - Italia 7
BE - Belgio 6
LT - Lituania 6
PH - Filippine 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
EG - Egitto 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
KE - Kenya 4
PK - Pakistan 4
UY - Uruguay 4
VE - Venezuela 4
CH - Svizzera 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KG - Kirghizistan 3
NG - Nigeria 3
PY - Paraguay 3
TN - Tunisia 3
AZ - Azerbaigian 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
ME - Montenegro 2
MY - Malesia 2
RO - Romania 2
TT - Trinidad e Tobago 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TW - Taiwan 1
Totale 4.357
Città #
Singapore 300
San Jose 174
Ashburn 167
Chandler 162
Houston 76
Ho Chi Minh City 72
Hefei 66
Tokyo 55
Beijing 54
Hanoi 49
New York 48
Redmond 45
Dublin 43
Lauterbourg 43
Kraków 42
São Paulo 35
Los Angeles 33
Jacksonville 32
San Mateo 31
Hong Kong 30
Jakarta 30
The Dalles 28
Boston 26
Milan 26
Helsinki 25
Cattolica 23
Frankfurt am Main 21
Seoul 19
Wilmington 19
Kent 18
Nanjing 17
Rome 17
Santa Clara 16
Buffalo 14
Chennai 14
Dallas 14
Orem 14
Brooklyn 13
Seattle 13
Dearborn 12
Lawrence 12
Princeton 12
Lappeenranta 11
Nanchang 11
Paris 11
Munich 10
Rio de Janeiro 10
Roubaix 10
Chicago 9
Council Bluffs 9
Guayaquil 9
Haiphong 9
Marseille 9
Mexico City 9
Montreal 9
Poplar 9
Stockholm 9
Warsaw 9
Düsseldorf 8
Moscow 8
Norwalk 8
Phoenix 8
Redwood City 8
St Louis 8
Amsterdam 7
Belo Horizonte 7
Bexley 7
Johannesburg 7
Mumbai 7
Pune 7
Ann Arbor 6
Brussels 6
Hải Dương 6
Nuremberg 6
Woodbridge 6
Ankara 5
Atlanta 5
Biên Hòa 5
Boardman 5
Brasília 5
Bremen 5
Curitiba 5
Denver 5
Dhaka 5
Fuzhou 5
London 5
Manaus 5
Monza 5
Portsmouth 5
Tashkent 5
Tianjin 5
Albuquerque 4
Baghdad 4
Cairo 4
Hyderabad 4
Jinan 4
Montevideo 4
Nürnberg 4
Ottawa 4
Quito 4
Totale 2.349
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 263
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 173
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 154
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort) 152
Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe 137
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 136
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons 133
Liver fibrosis progression and clinical outcomes are intertwined: Role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCVcoinfected patients with detectable HCV-RNA A MASTER cohort study 133
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 131
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 129
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 126
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 116
Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy 108
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 99
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-up 99
A systematic review of dalbavancin efficacy as a sequential therapy for infective endocarditis 96
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 96
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational Study 91
Heteroresistance and clinical outcomes: knowledge gaps 90
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): Protocol for an open-label, randomised controlled trial 87
Survival in HIV-infected patients after a cancer diagnosis in the cART era: Results of an Italian multicenter study 87
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 84
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice 83
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors 83
Autochthonous dengue outbreak in Rome, Italy, in 2023 82
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 82
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience 80
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy 80
Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received 78
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir 74
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response 73
Treatment with valacyclovir during pregnancy for prevention of congenital cytomegalovirus infection: a real-life multicenter Italian observational study 71
Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak 69
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort 69
The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV positive individuals before the start of antiretroviral therapy 69
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19 68
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 66
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 65
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 63
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure 63
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 61
New advances in management and treatment of cardiac implantable electronic devices infections 60
Evolving phenotypes of non-hospitalized patients that indicate long COVID 59
Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis 59
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 57
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask 48
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 37
Totale 4.419
Categoria #
all - tutte 17.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 2 14 2
2021/2022164 6 9 1 6 7 4 11 30 7 7 36 40
2022/2023413 62 61 31 48 36 50 13 36 50 4 13 9
2023/2024219 10 54 1 15 4 39 13 11 3 4 42 23
2024/2025755 5 10 47 9 38 19 51 35 70 72 205 194
2025/20262.231 357 119 220 409 367 98 315 103 126 117 0 0
Totale 4.419